Search
for
Sort by
Research 151–180 of 1000+
- Hepatitis Lupus in Systemic Lupus Erythematosus in Male Patients
- Netherton's syndrome: A syndrome of elevated IgE and characteristic skin and hair findings
- Immunologic adverse reactions of β-blockers and the skin (Review)
- Facial hair enhancement with minoxidil—an off-label use
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Finasteride-induced recurrent aphthous ulceration–like lesions: a case report with dechallenge–rechallenge confirmation
- Image3_Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network.TIFF
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Reactivation of Alopecia Areata After Dupilumab Therapy for Atopic Dermatitis
- A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective
- Overlapping of DRESS and Stevens-Johnson syndrome due to first-line antituberculosis drugs: a case report
- Therapeutic Options to Refractory Alopecia Areata
- The Hidden Epidemic of Topical Steroid Use: Prevalence and Impact Among Jordan’s General Population
- Efficacy and safety of botulinum toxin A in the treatment of female pattern hair loss
- Concept of tinea capitis
- A Case of Contact Allergic Dermatitis to Topical Minoxidil
- Misdiagnosis of eosinophilic cystitis: A case report and literature review
- To σύνδρομο της δερματίτιδας από λείξη των άκρων στο σκύλο
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- JAK Inhibitors for Treatment of Alopecia Areata
- Topical drug delivery strategies for enhancing drug effectiveness by skin barriers, drug delivery systems and individualized dosing
- Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm
- Pili Torti: A Feature of Numerous Congenital and Acquired Conditions
- SMART Pharmacists Serving the New Needs of the Post-COVID Patients, Leaving No-One Behind
- Hidradenitis Suppurativa Tunnels: Unveiling a Unique Disease Entity
- Oral Low-Dose Naltrexone in the Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris: An Uncontrolled Open-Label Prospective Study
- Spontaneous complete resolution of alopecia totalis post SARS-CoV-2 infection
- Hair transplantation: A brief review
- Abstracts from the 4th Annual Student Medical Summit
- Annual Convention in the Time of COVID